These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 34915108)
1. Use of Pean de Ponfilly-Sotier M; Besson FL; Gomez L; Ottaviani S; Dieudé P; Pavy S; Mariette X; Seror R; Nocturne G Joint Bone Spine; 2022 May; 89(3):105325. PubMed ID: 34915108 [TBL] [Abstract][Full Text] [Related]
2. Diagnosing polymyalgia rheumatica on Yuge S; Nakatani K; Yoshino K; Koyama T Ann Nucl Med; 2018 Oct; 32(8):573-577. PubMed ID: 29948622 [TBL] [Abstract][Full Text] [Related]
3. Diagnostic value of [18F]FDG-PET/CT in polymyalgia rheumatica: a systematic review and meta-analysis. van der Geest KSM; Treglia G; Glaudemans AWJM; Brouwer E; Jamar F; Slart RHJA; Gheysens O Eur J Nucl Med Mol Imaging; 2021 Jun; 48(6):1876-1889. PubMed ID: 33372248 [TBL] [Abstract][Full Text] [Related]
4. On the use of Giraud N; Verhoeven F; Wendling D; Prati C Joint Bone Spine; 2022 Oct; 89(5):105377. PubMed ID: 35288266 [No Abstract] [Full Text] [Related]
5. Similarities and differences in fluorodeoxyglucose positron emission tomography/computed tomography findings in spondyloarthropathy, polymyalgia rheumatica and rheumatoid arthritis. Yamashita H; Kubota K; Takahashi Y; Minamimoto R; Morooka M; Kaneko H; Kano T; Mimori A Joint Bone Spine; 2013 Mar; 80(2):171-7. PubMed ID: 22749663 [TBL] [Abstract][Full Text] [Related]
6. Diagnostic value of 18F-fluorodeoxyglucose positron emission tomography and computed tomography for differentiating polymyalgia rheumatica and rheumatoid arthritis: Using classification and regression tree analysis. Ikuma D; Sawa N; Yamanouchi M; Oba Y; Mizuno H; Suwabe T; Hoshino J; Ubara Y Mod Rheumatol; 2024 Mar; 34(3):474-478. PubMed ID: 37279960 [TBL] [Abstract][Full Text] [Related]
7. Abnormalities at three musculoskeletal sites on whole-body positron emission tomography/computed tomography can diagnose polymyalgia rheumatica with high sensitivity and specificity. Owen CE; Poon AMT; Yang V; McMaster C; Lee ST; Liew DFL; Leung JL; Scott AM; Buchanan RRC Eur J Nucl Med Mol Imaging; 2020 Sep; 47(10):2461-2468. PubMed ID: 32090280 [TBL] [Abstract][Full Text] [Related]
8. Various forms of (18)F-FDG PET and PET/CT findings in patients with polymyalgia rheumatica. Rehak Z; Vasina J; Nemec P; Fojtik Z; Koukalova R; Bortlicek Z; Rehakova D; Adam J; Vavrusova A; Adam Z Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2015 Dec; 159(4):629-36. PubMed ID: 26006092 [TBL] [Abstract][Full Text] [Related]
9. Utility of 18F-fluoro-dexoxyglucose positron emission tomography for the diagnosis of polymyalgia rheumatica: a controlled study. Sondag M; Guillot X; Verhoeven F; Blagosklonov O; Prati C; Boulahdour H; Wendling D Rheumatology (Oxford); 2016 Aug; 55(8):1452-7. PubMed ID: 27107429 [TBL] [Abstract][Full Text] [Related]
19. Polymyalgia Rheumatica: A syndrome with an enthesitic subset? Comment on: "Use of 18F FDG PET-CT to discriminate polymyalgia rheumatica and atypical spondylarthritis in clinical practice" by Marie Pean de Ponfilly-Sotier et al. Joint Bone Spine 2021;89:105325. Falsetti P; Conticini E; Baldi C; Bardelli M; Gentileschi S; D'Alessandro R; Al Khayyat SG; Cantarini L; Frediani B Joint Bone Spine; 2022 Oct; 89(5):105378. PubMed ID: 35288264 [No Abstract] [Full Text] [Related]
20. Role of Slart RHJA; Nienhuis PH; Glaudemans AWJM; Brouwer E; Gheysens O; van der Geest KSM J Nucl Med; 2023 Apr; 64(4):515-521. PubMed ID: 37011940 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]